Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net income $ 80,468 $ 19,216
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 8,806 7,822
Amortization of right-of-use assets 17,773 16,883
Credit loss recovery 25 55
Stock-based compensation 7,653 7,551
Deferred taxes, net (2,847) 6,050
Unrealized foreign exchange (gains) losses (298) 276
Net realized gains on marketable debt securities, available-for-sale (78) (180)
Other non-cash items 361 930
Changes in operating assets and liabilities:    
Commissions receivable (5,297) (1,928)
Prepaid expenses 925 1,988
Advances and loans (2,434) (36,905)
Other assets (1,076) (1,087)
Accounts payable and other liabilities 4,020 (1,373)
Income tax receivable/payable 1,932 (5,024)
Accrued bonuses and other employee related expenses 11,223 (12,145)
Deferred compensation and commissions (4,499) (17,593)
Operating lease liabilities (15,889) (13,504)
Other liabilities (1,175) 702
Net cash provided by (used in) operating activities 99,593 (28,266)
Cash flows from investing activities    
Acquisition of businesses, net of cash received 229 (11,821)
Purchases of marketable debt securities, available-for-sale (291,063) (179,221)
Proceeds from sales and maturities of marketable debt securities, available-for-sale 248,540 175,226
Purchases of securities, held-to-maturity (9,500) 0
Issuances of employee notes receivable (40) (243)
Payments received on employee notes receivable 290 90
Purchase of property and equipment (4,238) (5,412)
Net cash used in investing activities (55,782) (21,381)
Cash flows from financing activities    
Taxes paid related to net share settlement of stock-based awards (3,230) (1,955)
Proceeds from issuance of shares pursuant to employee stock purchase plan 369 371
Principal payments on notes payable to former stockholders 0 (6,564)
Principal payments on stock appreciation rights liability (1,481) (1,251)
Principal payments on contingent and deferred consideration (1,739) (420)
Net cash used in financing activities (6,081) (9,819)
Effect of currency exchange rate changes on cash and cash equivalents 125 (92)
Net increase (decrease) in cash and cash equivalents 37,855 (59,558)
Cash and cash equivalents at beginning of period 243,152 232,670
Cash and cash equivalents at end of period 281,007 173,112
Supplemental disclosures of cash flow information    
Interest paid during the period 734 1,208
Income taxes paid, net $ 30,168 $ 6,849